Physician profile
Umesh K Pathak
NPI 1306802624
$381.44
in general payments reported to CMS, 2019-2025
9 companies · $85.20 in 2025
The $85.20 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.26 · 2020: $23.11 · 2021: $74.30 · 2022: $36.14 · 2023: $70.93 · 2024: $55.50 · 2025: $85.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $142.71 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sanofi Pasteur INC. | $48.02 | 2022-2023 | |
| Biofire Diagnostics, LLC | $40.00 | 2021 | |
| Glaxosmithkline, LLC. | $38.10 | 2019-2023 | Bexsero, Pediarix |
| Cumberland Pharmaceuticals, INC. | $37.59 | 2020-2025 | Kristalose |
| Phadia US INC. | $35.18 | 2024-2025 | Immunocap |
| Cipher Pharmaceuticals US LLC | $17.62 | 2025 | Spinosad, Natroba |
| Takeda Pharmaceuticals U.S.A., INC. | $11.18 | 2021 | |
| Shire North American Group INC | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umesh Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.